Towards the end of Q2, Vitamin B5 prices are expected to follow varied trends worldwide, influenced by several factors. In Asia, a persistent downward trend is likely to continue, impacting profit margins for local manufacturers and suppliers in the global trade. This decline is primarily due to erratic demand patterns and a scarcity of new inquiries. Conversely, in western markets especially Europe and the US, prices are stable and relatively higher, attributed to delays in shipments from China, a key exporter in the Vitamin B5 market.

In China, several factors contributing to a decline in Vitamin B5 prices. Firstly, although some manufacturers have reduced their production output or are engaging in extended summer maintenance, the overall market sentiment remains weak. This weakness can be attributed to an ample supply of Vitamin B5, which is sufficient to meet current demand despite the reduction in production. Additionally, many long-term contracts have already been concluded or are pending, ensuring a steady flow of Vitamin B5 supply into the market. Another critical factor is the sluggish demand within the domestic market. This lack of robust demand further contributes to the weak market sentiment, as there is no substantial pull from the market to absorb the existing supply. In such a scenario, manufacturers could struggle to find buyers for their products, which can lead to excess inventory and pressure to lower Vitamin B5 prices to stimulate sales.

In the USA, suppliers are currently attempting to raise the price of Vitamin B5, citing low stocks and delays in material due to ongoing concerns in the Red Sea region. Furthermore, market disruptions in other global regions, including reduced production output, scheduled maintenance periods, and supply delays, are additional factors influencing the USA Vitamin B5 market. Despite these challenges, the current expectation is that Vitamin B5 prices in the USA would experience only a marginal increase.

Similarly, the European market for Vitamin B5 is expected to follow a comparable trajectory with tight supply from EU-based suppliers. Additionally, the European Central Bank's decision to cut interest rates in June, ahead of the US Federal Reserve and the Bank of England, is intended to reduce borrowing costs as inflation recedes after years of rate hikes. This rate cut, the first in nearly five years, reduces the benchmark rate in the eurozone from an all-time high of 4% to 3.75%, potentially easing financial strains on companies and consumers. This move could stimulate demand and provide support to the Vitamin B5 market.

According to ChemAnalyst's analysis, the Vitamin B5 market across the globe is anticipated to maintain stable operations in the near future. Most regions are adopting a "wait-and-see" approach, indicating cautious optimism about market conditions. Supply levels are generally sufficient, and suppliers are focused on preserving their market share and managing existing stock levels.